MARTINI® Asti Celebrates 150th Anniversary With Sustainability Milestone
15.7.2021 15:04:00 EEST | Business Wire | Press release
After decades spent pioneering sustainable practices in the vineyards of northwest Italy, MARTINI, the world’s number one Italian sparkling wine and vermouth from family-owned Bacardi, is proud to announce that all its Asti grape suppliers are on track to being certified sustainable in 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005597/en/
The MARTINI Santo Stefano Belbo winery, located in the heart of the Asti region and responsible for producing 30% of all the grape ‘must’ (grape juice) for MARTINI Asti, was recently certified sustainable by Equalitas, the most comprehensive sustainability standard in Italian wine making, following an audit by certification body, Valoritalia. Of the remaining 70%, more than two-thirds of the grape must suppliers – cooperatives representing hundreds of small grape growers – have also been certified sustainable by Equalitas with the remainder on track to be certified this year. (Photo: Business Wire)
The timing could not be more perfect. As Bacardi celebrates this major sustainability milestone, it’s also celebrating 150 years since Martini & Rossi produced its first samples of ‘moscato spumante d’Asti’ to meet demand from customers around the world back in 1871.
The MARTINI Santo Stefano Belbo winery, located in the heart of the Asti region and responsible for producing 30% of all the grape ‘must’ (grape juice) for MARTINI Asti, was recently certified sustainable by Equalitas, the most comprehensive sustainability standard in Italian wine making, following an audit by certification body Valoritalia. Of the remaining 70%, more than two-thirds of the grape must suppliers – cooperatives representing hundreds of small grape growers – have also been certified sustainable by Equalitas with the remainder on track to be certified this year.
Together with the recent announcement that the 10 botanicals used to create BOMBAY SAPPHIRE® will be certified sustainable in 2021, this news is another major step towards Bacardi achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.
It was back in 1987 that, in true pioneering style, MARTINI established a center dedicated to sustainable business practices called L'Osservatorio MARTINI – the MARTINI Observatory. Located in the heart of the region and led by a local agronomist expert in the cultivation of vineyards, L'Osservatorio MARTINI has introduced many sustainability practices to the region – from advising on natural ways to manage pests through to integrated viticulture, looking at the balance of what is grown in the microclimates of the Asti region.
“There is a deep connection between MARTINI, the land and the people – it’s a solid foundation for making quality wine,” said Giorgio Castagnotti, Director of the MARTINI Operations Center in Pessione, Italy. “We have worked closely with the same farming communities growing the finest Moscato grapes in the same beautiful hills for generations – in fact for the last 150 years – and we want to continue to do so for generations to come. It’s always made sense then for us support our grape growers through our sustainability initiatives.”
The steep, sun-drenched hills of Asti in the heart of the Piedmont region of Italy, are the ideal growing environment for the Moscato Bianco grape, and have a DOCG designation, the highest quality level for Italian wines. Expertly harvested in late summer by more than 200 small growers – known collectively as the Conferenti – the grapes are pressed quickly to capture the desired natural flavors in the fresh juice called ‘must’. Through fermentation, this ‘mosto’ becomes the basis of MARTINI Asti’s delicate flavors including notes of peach, sweet wild sage, fresh pear and pineapple.
Stefano Stefanucci, Director of Equalitas, said: “This is a big achievement for MARTINI. Equalitas only works with third-party auditors who are experts with a deep knowledge of the wine sector and the certification process is wholly holistic. Equalitas embraces three sustainability pillars – environmental, ethical and economical – and takes into consideration everything from a winery’s carbon footprint and water consumption through to fair commercial terms for farmers and good social practices including training and welfare.”
Victoria Morris, Global VP MARTINI, added: “Being a family-owned company genuinely makes a difference to the way Bacardi approaches sustainability. We are committed to doing the right thing for the environment, for our suppliers and for their communities for the long term. I am incredibly proud of Giorgio and his team. They are masters of their craft and have reached a new milestone in the long history of MARTINI. It’s the perfect way to toast 150 years of MARTINI Asti!”
Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/.
Always drink responsibly.
About MARTINI
One of the most iconic brands in the world, MARTINI® is the leading name in Italian winemaking and a purveyor of the highest quality aromatized and sparkling wines. The award- winning, vibrant and bittersweet taste of the MARTINI range is the result of secret blends of more than 40 botanicals sourced from the finest locations across the globe. First created in 1863 in Turin, Italy, the MARTINI portfolio today includes: MARTINI Fiero, MARTINI Riserva Speciale Rubino, MARTINI Riserva Speciale Ambrato, MARTINI Riserva Speciale Bitter, MARTINI Bianco, MARTINI Rosato, MARTINI Rosso, MARTINI Extra Dry, MARTINI Asti, MARTINI Prosecco and MARTINI Rosé Extra Dry. For more information, please visit www.martini.com.
MARTINI and the ball & bar logo are trademarks. MARTINI is part of the portfolio of Bacardi Limited, headquartered in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
About Bacardi
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com or follow us on Twitter, LinkedIn or Instagram.
About Equalitas
Equalitas Srl was founded in 2015 by Federdoc ed Unione Italiana Vini, with a view to building on the technical and cultural achievements of a movement of stakeholders committed to developing wine sustainability, in support of the Forum for Wine Sustainability and the UIV-Tergeo project. The initial partnership was later completed and strengthened by the participation of CSQA Certificazioni, one of the leading agrifood certification bodies in Italy; Valoritalia, the first Wine Denomination of Origin certifying body; Gambero Rosso, Italy’s largest multimedia publisher specializing in food and wine; and 3AVino, a financial company targeting the wine-growing industry. A broad set of skills and expertise that can ensure a comprehensive and integrated approach to sustainability, from the point of view of its economic, social and environmental components. Visit www.equalitas.it.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005597/en/
Contact information
Andrew Carney, Communications Director Europe, Australia & New Zealand, Bacardi, acarney@bacardi.com
Jessica Merz, Global Head of Corporate Communications, Bacardi, jmerz@bacardi.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release
The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r
The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 12:00:00 EEST | Press release
The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that elevates high-performance riders and horses to their rightful place on the world stage. Built on merit, integrity, and excellence, the PJL brings together the world’s best athletes to compete for the biggest prize pot in the discipline’s history, helping to create a more resilient, long-term financial model for the sport. Represented by sixteen teams, the PJL will introduce an industry-first rider selection process from a pool of 250 of the world’s leading riders. World-class, immersive events will unfold across fourteen ic
Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 12:00:00 EEST | Press release
Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkbj) for the treatment of spastic cerebral palsy (CP). On top of safety and tolerability, the study will evaluate improvements in daily functioning, quality of life, motor abilities, and neurodevelopmental measures of the Cenegermin-bkbj intranasal formulation. CP is the most common motor disability in childhood, caused by injury or changes during early brain development. The most prevalent form, spastic CP, leads to muscle stiffness and difficulty with movement.2 “Cerebral palsy is a devastating disease, and for patients and families there are still no proven treatments beyond supportive care,” said Marcello Allegretti, Chief Scientific Officer at Dompé. “With our emerging intranasal NGF p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
